CLEVELAND, Nov. 10, 2014 /PRNewswire/
-- DATATRAK International, Inc. (OTCQX: DTRK), the
leader in developing cloud-based, unified eClinical®
technologies for the clinical trials industry, today announced the
expansion of office locations to include downtown Chicago in early 2015.
"Chicago offers
DATATRAK an exceptional talent pool, and is easily
accessible by our global clients," said Laurence P. Birch, DATATRAK
Chairman and CEO. "We considered many locations, including
Austin and San Francisco, but ultimately chose
Chicago for these reasons, and to
take advantage of the growing technology industry and the presence
of leading Life Sciences companies. We are actively hiring in
Chicago and will continue to focus
our recruiting efforts in the Chicagoland area."
DATATRAK has leased 10,000+ square feet of office space
at 130 E. Randolph in the historic Prudential Building.
Beginning in Q1 2015, the new space will house the -recently hired
Chicago team members with ample
room for growth.
DATATRAK will continue to operate in its four
existing locations, including Cary Research Triangle Park (RTP),
North Carolina; Bryan, Texas; Cleveland, Ohio, and London, UK.
DATATRAK is a worldwide technology and consulting
company delivering eClinical solutions and related services for the
clinical trials industry. The company delivers a portfolio of
software solutions through the unified eClinical® platform,
safely accelerating clinical research, from Concept to
Cure®.
Join DATATRAK Thought Leaders:
- Twitter
- LinkedIn
- SlideShare
- The DATATRAK Blog
Tweet: .@DATATRAKinc hiring, opening new office in
#Chicago Q1 2015 #jobs http://bit.ly/1ABsDIt
About
DATATRAK International,
Inc.
DATATRAK International is a worldwide
technology and services company delivering unified
eClinical® solutions and related services for the
clinical trials industry. DATATRAK built its
multi-component, comprehensive solution on a single, unified
platform and expanded this concept to include services delivery via
DATATRAK's Clinical and Consulting Services group.
The Company delivers a complete portfolio of software products
designed to accelerate the reporting of clinical research data from
sites to sponsors and ultimately regulatory authorities, faster and
more efficiently than loosely integrated technologies. The
DATATRAK ONE® software solution, deployed
worldwide through an ASP or Enterprise Transfer offering, supports
Preclinical and Phase I - Phase IV drug and device studies in
multiple languages throughout the world. DATATRAK is
located in Cleveland, Ohio;
Bryan, Texas; Cary (RTP),
North Carolina and London, England. For more information,
visit http://www.datatrak.com.
Except for the historical information contained in this press
release, the statements made in this release are forward-looking
statements. These forward-looking statements
are made based on management's expectations, assumptions, estimates
and current beliefs concerning the operations, future results and
prospects of the Company and are subject to uncertainties and
factors which are difficult to predict and, in many instances, are
beyond the control of the Company, and which could cause actual
results to differ materially from those contemplated in these
forward-looking statements. For a list of certain factors that may
cause actual results to differ materially from those contemplated
in these forward looking statements, please see the Company's
report filed with the OTCQX Market on August
14, 2014 announcing its results for the second quarter of
2014. The Company undertakes no obligation to update publicly or
revise any forward-looking statement whether as a result of new
information, future events or otherwise.
SOURCE DATATRAK International, Inc.